Viewing Study NCT01133756

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:34 PM

Ignite Modification Date: 2025-12-30 @ 8:47 PM

Study NCT ID: NCT01133756

Status: TERMINATED

Last Update Posted: 2023-06-22

First Post: 2010-05-21

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125

Sponsor: Eisai Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module